High-Risk Individuals’ Willingness to Pay for Diabetes Risk-Reduction Programs
- 1 June 2006
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (6) , 1351-1356
- https://doi.org/10.2337/dc05-2221
Abstract
OBJECTIVE—The purpose of this study was to estimate how much at-risk individuals are willing to pay for type 2 diabetes primary prevention programs.Keywords
This publication has 19 references indexed in Scilit:
- The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose ToleranceAnnals of Internal Medicine, 2005
- Using stated preference and revealed preference modeling to evaluate prescribing decisionsHealth Economics, 2003
- Lifetime Risk for Diabetes Mellitus in the United StatesJAMA, 2003
- Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 DiabetesDiabetes Care, 2003
- Unexpected yes- and no-answering behaviour in the discrete choice approach to elicit willingness to pay: a methodological comparison with payment cards.International Journal of Health Economics and Management, 2003
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- Combining sources of preference dataJournal of Econometrics, 1998
- Predicting Behavior from Intention-to-Buy Measures: The Parametric CaseJournal of Marketing Research, 1995
- Willingness to pay for lipid lowering: a health production function approachApplied Economics, 1993